Targeting DNA to Cells with Basic Fibroblast Growth Factor (FGF2)

• Published in: The Journal of biological chemistry 1996-12, Vol.271 (52), p.33647-33653
• Main Authors: Sosnowski, Barbara A., Gonzalez, Ana Maria, Chandler, Lois A., Buechler, Ying J., Pierce, Glenn F., Baird, Andrew
• Format: Article
• Language: English
• Subjects: 3T3 Cells; Animals; COS Cells; Cricetinae; Cytochrome c Group - metabolism; DNA - metabolism; Dose-Response Relationship, Drug; Fibroblast Growth Factor 2 - genetics; Fibroblast Growth Factor 2 - metabolism; Gene Targeting; Histones - metabolism; Mice; Receptors, Fibroblast Growth Factor - metabolism
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.271.52.33647

Ligand-mediated targeting of DNA was validated by condensing a plasmid DNA encoding the β-galactosidase (β-gal) gene with a basic fibroblast growth factor (FGF2) that was first chemically conjugated to polylysine (K). The conditions that gave optimal binding of this FGF2 to DNA also generated the highest level of β-gal expression when added to FGF2 target cells like COS-1, 3T3, baby hamster kidney (BHK), or endothelial cells. This β-gal activity increased in a time- and dose-dependent manner and was dependent on the inclusion of FGF2 in the complex. FGF receptor specificity was demonstrated by competition of the complex with FGF2 and heparin, and by the failure of cytochrome c or histone H1 to mimic the gene-targeting effects of FGF2. The expression of β-gal was also endosome dependent because chloroquine increased β-gal expression 8-fold and endosome disruptive peptides increased expression of β-gal 26-fold. Taken together these findings establish that DNA can be introduced into cells through the high affinity FGF receptor complex, and while its efficiency will require significant enhancements to achieve sustained and elevated transgene expression, the possibility that the technique could be used to deliver DNAs encoding cytotoxic molecules is discussed.